Derived from living organisms, these therapeutic agents, including monoclonal antibodies, vaccines, and gene therapies, represent a departure from traditional drugs.
In 2024, the ascent of biopharmaceuticals will define a transformative trend in biotechnology. Derived from living organisms, these therapeutic agents, including monoclonal antibodies, vaccines, and gene therapies, represent a departure from traditional drugs.